Contact

Merge Sets Second Quarter 2012 Earnings Call

Merge Sets Second Quarter 2012 Earnings Call

.

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, announced today the scheduling of its second quarter 2012 earnings call, which will be held at 8:30 AM ET on Wednesday, August 1, 2012.

The call will address the second quarter results, followed by a business discussion of the company’s continued market outlook and strategies for 2012.

The second quarter 2012 earnings results for Merge will be published prior to the earnings call. Investors may listen to the conference call live via telephone by dialing  888.267.0102 (US and Canada) or (706) 643-0988 (International) and referencing Conference ID Number 98263095.

The call can be accessed over the Internet at Merge Healthcare Web Cast. A replay via the Internet or phone will be available after the call at http://www.merge.com/Company/Investors/Conference-Call-Info.aspx.

About Merge
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Contact:
Lesley Weisenbacher
Vice President, Marketing
312-540-6623
lesley.weisenbacher@merge.com

 Download this press release >>

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap